Read more
16:20 · 22 October 2020

Align Tech. stock surged over 30% on Q3 sales

-
-
Open account Download free app
Align Technology (ALGN.US) - the maker of the Invisalign, which is the alternative to metal braces, reported quarterly earnings of $2.25 per share well above the 67 cents per share consensus estimate. Revenue also topped market estimates by a wide margin.
Company attributed its strong quarterly figures to a new “teen and mom consumer-focused campaign,” and saw “an uptick in consumer engagement from new social-media influencers like Charli D’Amelio and Marsai Martin, and a 25.6% year-over-year increase in teenagers using Invisalign clear aligners.” Chief Executive Joe Hogan said in a statement.
Align Technology (ALGN.US) - shares rose more than 23% in the extended session after the company released its third-quarter earnings results. Align stock launched today's trading session with a massive bullish price gap and hit all-time high of $459.33. Source: xStation5
2 April 2026, 18:32

Daily summary: Hopes for peace and space stocks in the spotlight

2 April 2026, 17:58

Globalstar: Are we headed for a battle of giants over orbit?

2 April 2026, 17:43

Intuitive Machines: Flywheel of the space economy?

2 April 2026, 15:33

Tesla disappoints with deliveries - Again

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.